Counterfeit medicine has become a significant problem in developing countries, including Bangladesh. Estimates suggest that fake drugs can make up 30% of all medicines sold in the open market at any given time.
Arogga is a Bangladeshi startup aiming to nip the issue in the bud by making genuine and affordable medication more accessible.
With this goal in mind, the company has recently raised US$4 million in fresh capital, bringing Arogga’s total seed funding to US$5.5 million. The new round was led by The Venture Collective, a US-based venture capital firm.